​

Natera (NTRA) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

NTRA Stock Forecast

Natera stock forecast is as follows: an average price target of $151.50 (represents a -6.41% downside from NTRA’s last price of $161.88) and a rating consensus of 'Buy', based on 11 wall street analysts offering a 1-year stock forecast.

NTRA Price Target

The average price target for Natera (NTRA) is $151.50 based on 1-year price targets from 11 Wall Street analysts in the past 3 months, with a price target range of $182.00 to $132.00. This represents a potential -6.41% downside from NTRA's last price of $161.88.

NTRA Analyst Ratings

Buy

According to 11 Wall Street analysts, Natera's rating consensus is 'Buy'. The analyst rating breakdown for NTRA stock is 1 'Strong Buy' (9.09%), 10 'Buy' (90.91%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Natera Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 13, 2024Tycho PetersonJefferies$182.00$114.5758.85%12.43%
Nov 13, 2024Catherine Ramsey SchulteRobert W. Baird$160.00$114.5739.65%-1.16%
Oct 29, 2024Kyle MiksonCanaccord Genuity$150.00$120.7124.26%-7.34%
Sep 13, 2024Dave WestenbergPiper Sandler$150.00$125.1219.88%-7.34%
Aug 27, 2024Kyle MiksonCanaccord Genuity$145.00$118.1122.77%-10.43%
Aug 13, 2024Tejas SavantMorgan Stanley$132.00$115.2514.53%-18.46%
Aug 09, 2024Catherine Ramsey SchulteRobert W. Baird$120.00$107.7011.42%-25.87%
Jun 25, 2024Doug SchenkelWolfe Research$135.00$107.4125.69%-16.60%
Jun 03, 2024Tycho PetersonJefferies$142.00$106.5333.30%-12.28%
May 14, 2024David WestenbergPiper Sandler$120.00$103.3316.13%-25.87%
May 13, 2024Mark MassaroBTIG$125.00$105.2918.72%-22.78%
May 10, 2024Catherine Ramsey SchulteRobert W. Baird$117.00$95.5522.45%-27.72%
Apr 05, 2024Eve BursteinBernstein$120.00$92.3629.93%-25.87%
Nov 14, 2022Credit Suisse$55.00$40.4436.00%-66.02%
Aug 17, 2022David WestenbergPiper Sandler$70.00$52.5733.16%-56.76%
Aug 05, 2022J.P. Morgan$100.00$50.9996.12%-38.23%
May 15, 2022David WestenbergPiper Sandler$60.00$34.2075.44%-62.94%
Apr 25, 2022Stephens$54.00$38.4840.33%-66.64%
Apr 19, 2022Goldman Sachs$80.00$37.41113.85%-50.58%
May 25, 2021Sandy DraperGuggenheim$129.00$90.5142.53%-20.31%

The latest Natera stock forecast, released on Nov 13, 2024 by Tycho Peterson from Jefferies, set a price target of $182.00, which represents a 58.85% increase from the stock price at the time of the forecast ($114.57), and a 12.43% increase from NTRA last price ($161.88).

Natera Price Target by Period

1M3M12M
# Anlaysts-313
Avg Price Target-$164.00$138.31
Last Closing Price$161.88$161.88$161.88
Upside/Downside-100.00%1.31%-14.56%

In the current month, the average price target of Natera stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Natera's last price of $161.88. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Nov 13, 2024Cowen & Co.BuyBuyHold
Nov 13, 2024JefferiesBuyBuyHold
Oct 29, 2024Canaccord GenuityBuyBuyHold
Oct 16, 2024UBSBuyBuyHold
Sep 16, 2024BTIGBuyBuyHold
Sep 13, 2024UBSBuyBuyHold
Sep 13, 2024Piper SandlerOverweightOverweightHold
Sep 10, 2024Cowen & Co.BuyBuyHold
Aug 27, 2024Canaccord GenuityBuyBuyHold
Aug 13, 2024Morgan StanleyOverweightOverweightHold
Aug 09, 2024UBSBuyBuyHold
Aug 09, 2024BTIGBuyBuyHold
Aug 05, 2024Cowen & Co.BuyBuyHold
Jul 25, 2024Piper SandlerOverweightOverweightHold
Jun 25, 2024Wolfe ResearchOutperformOutperformHold
Jun 03, 2024JefferiesBuyInitialise
May 14, 2024Piper SandlerOverweightOverweightHold
May 13, 2024BTIGBuyBuyHold
May 10, 2024Cowen & Co.BuyBuyHold
Apr 05, 2024StephensBuyBuyHold
Apr 05, 2024BernsteinOutperformUpgrade
Feb 20, 2024StephensBuyBuyHold
Jan 17, 2024UBSBuyBuyHold
Dec 29, 2023BTIGBuyBuyHold
Nov 13, 2023Raymond JamesStrong BuyUpgrade
Dec 16, 2022Piper SandlerOverweightOverweightHold
Aug 17, 2022Piper SandlerOverweightOverweightHold
May 15, 2022Piper SandlerOverweightOverweightHold

Natera's last stock rating was published by Cowen & Co. on Nov 13, 2024. The company gave NTRA a "Buy" rating, the same as its previous rate.

Natera Financial Forecast

Natera Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue-------------$268.31M$261.40M$241.76M$217.25M$210.64M$198.20M$194.13M$173.03M$158.12M$142.03M$152.32M$112.38M$98.14M$86.47M$94.01M$83.24M$77.91M
Avg Forecast$586.58M$570.94M$535.78M$523.78M$473.25M$462.52M$441.42M$425.24M$409.91M$361.43M$343.00M$316.31M$300.00M$259.27M$241.67M$227.13M$215.57M$206.66M$193.67M$176.56M$168.59M$151.89M$128.78M$114.37M$106.61M$87.26M$73.11M$85.06M$77.84M$73.45M
High Forecast$615.45M$599.04M$562.15M$549.56M$496.54M$485.28M$463.15M$440.82M$419.44M$361.57M$343.00M$331.88M$312.84M$259.27M$253.56M$238.31M$226.18M$206.66M$193.67M$176.56M$168.59M$151.89M$128.78M$114.37M$106.61M$87.26M$73.11M$85.06M$77.84M$73.45M
Low Forecast$567.21M$552.09M$518.08M$506.48M$457.61M$447.24M$426.84M$417.74M$403.76M$361.30M$343.00M$305.86M$287.16M$259.27M$233.69M$219.63M$208.45M$206.66M$193.67M$176.56M$168.59M$151.89M$128.78M$114.37M$106.61M$87.26M$73.11M$85.06M$77.84M$73.45M
# Analysts9999888101157494643743474413889127
Surprise %-------------1.03%1.08%1.06%1.01%1.02%1.02%1.10%1.03%1.04%1.10%1.33%1.05%1.12%1.18%1.11%1.07%1.06%

Natera's average Quarter revenue forecast for Dec 23 based on 9 analysts is $300.00M, with a low forecast of $287.16M, and a high forecast of $312.84M. NTRA's average Quarter revenue forecast represents a 11.81% increase compared to the company's last Quarter revenue of $268.31M (Sep 23).

Natera EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts9999888101157494643743474413889127
EBITDA-------------$-105.58M$-112.43M$-133.72M$-135.47M$-113.82M$-138.32M$-133.18M$-135.52M$-145.93M$-111.00M$-59.10M$-69.67M$-51.85M$-53.37M$-31.06M$-30.81M$-18.45M
Avg Forecast$-303.02M$-294.94M$-276.78M$-270.58M$-244.47M$-238.93M$-228.03M$-219.67M$-211.76M$-186.71M$-177.19M$-164.42M$-154.98M$-133.94M$-124.84M$-149.47M$-129.73M$-112.49M$-105.42M$-135.88M$-91.76M$-82.68M$-70.10M$-75.32M$-58.03M$-47.50M$-39.79M$-37.16M$-42.37M$-39.98M
High Forecast$-293.02M$-285.20M$-267.64M$-261.64M$-236.40M$-231.04M$-220.50M$-215.80M$-208.58M$-186.64M$-177.19M$-131.54M$-148.34M$-133.94M$-120.72M$-119.58M$-103.78M$-112.49M$-105.42M$-108.71M$-91.76M$-82.68M$-70.10M$-60.26M$-58.03M$-47.50M$-39.79M$-29.73M$-42.37M$-39.98M
Low Forecast$-317.94M$-309.46M$-290.40M$-283.90M$-256.51M$-250.69M$-239.26M$-227.72M$-216.68M$-186.78M$-177.19M$-197.30M$-161.61M$-133.94M$-130.99M$-179.37M$-155.67M$-112.49M$-105.42M$-163.06M$-91.76M$-82.68M$-70.10M$-90.38M$-58.03M$-47.50M$-39.79M$-44.59M$-42.37M$-39.98M
Surprise %-------------0.79%0.90%0.89%1.04%1.01%1.31%0.98%1.48%1.76%1.58%0.78%1.20%1.09%1.34%0.84%0.73%0.46%

undefined analysts predict NTRA's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Natera's previous annual EBITDA (undefined) of $NaN.

Natera Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts9999888101157494643743474413889127
Net Income-------------$-109.03M$-110.80M$-136.94M$-142.57M$-121.48M$-145.15M$-138.59M$-140.56M$-151.27M$-116.03M$-63.85M$-76.41M$-58.32M$-59.64M$-35.37M$-35.18M$-23.14M
Avg Forecast$45.11M$39.07M$22.13M$11.85M$-31.13M$-37.50M$-42.57M$-49.96M$-60.62M$-71.12M$-85.25M$-171.10M$-95.29M$-118.54M$-134.63M$-155.54M$-134.56M$-177.06M$-184.23M$-141.40M$-160.85M$-158.80M$-138.03M$-81.38M$-76.41M$-83.40M$-72.69M$-42.32M$-67.74M$-67.77M
High Forecast$47.99M$41.57M$23.55M$12.60M$-29.79M$-35.88M$-40.74M$-40.99M$-54.31M$-68.07M$-81.59M$-136.88M$-87.46M$-113.45M$-128.84M$-124.44M$-107.64M$-177.06M$-184.23M$-113.12M$-160.85M$-158.80M$-138.03M$-65.11M$-76.41M$-83.40M$-72.69M$-33.86M$-67.74M$-67.77M
Low Forecast$43.17M$37.39M$21.18M$11.34M$-33.12M$-39.89M$-45.29M$-53.80M$-65.68M$-75.67M$-90.70M$-205.32M$-104.43M$-126.13M$-143.24M$-186.65M$-161.47M$-177.06M$-184.23M$-169.69M$-160.85M$-158.80M$-138.03M$-97.66M$-76.41M$-83.40M$-72.69M$-50.78M$-67.74M$-67.77M
Surprise %-------------0.92%0.82%0.88%1.06%0.69%0.79%0.98%0.87%0.95%0.84%0.78%1.00%0.70%0.82%0.84%0.52%0.34%

Natera's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. NTRA's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Natera SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts9999888101157494643743474413889127
SG&A-------------$154.74M$152.51M$149.63M$143.82M$147.67M$149.47M$147.63M$146.76M$128.49M$127.46M$108.33M$94.08M$75.68M$68.19M$65.68M$58.59M$56.72M
Avg Forecast$418.15M$407.00M$381.93M$373.38M$337.35M$329.71M$314.67M$303.13M$292.21M$257.65M$244.51M$182.26M$213.86M$184.82M$172.27M$165.69M$140.49M$147.32M$138.06M$150.63M$120.18M$108.28M$91.80M$81.53M$76.00M$62.20M$52.11M$78.58M$55.49M$52.36M
High Forecast$438.73M$427.03M$400.73M$391.76M$353.96M$345.94M$330.15M$314.24M$299.00M$257.75M$244.51M$218.71M$223.01M$184.82M$180.75M$198.83M$168.58M$147.32M$138.06M$180.75M$120.18M$108.28M$91.80M$81.53M$76.00M$62.20M$52.11M$94.30M$55.49M$52.36M
Low Forecast$404.34M$393.56M$369.32M$361.05M$326.21M$318.82M$304.27M$297.79M$287.82M$257.55M$244.51M$145.81M$204.70M$184.82M$166.58M$132.55M$112.39M$147.32M$138.06M$120.50M$120.18M$108.28M$91.80M$81.53M$76.00M$62.20M$52.11M$62.87M$55.49M$52.36M
Surprise %-------------0.84%0.89%0.90%1.02%1.00%1.08%0.98%1.22%1.19%1.39%1.33%1.24%1.22%1.31%0.84%1.06%1.08%

Natera's average Quarter SG&A projection for Dec 23 is $213.86M, based on 9 Wall Street analysts, with a range of $204.70M to $223.01M. The forecast indicates a 38.20% rise compared to NTRA last annual SG&A of $154.74M (Sep 23).

Natera EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts9999888101157494643743474413889127
EPS-------------$-0.95$-0.97$-1.23$-1.45$-1.25$-1.50$-1.45$-1.52$-1.63$-1.32$-0.74$-0.94$-0.72$-0.75$-0.45$-0.45$-0.33
Avg Forecast$0.36$0.32$0.18$0.10$-0.25$-0.30$-0.34$-0.40$-0.49$-0.57$-0.69$-0.71$-0.77$-0.96$-1.09$-1.16$-1.42$-1.44$-1.50$-1.49$-1.31$-1.29$-1.12$-1.02$-0.62$-0.68$-0.59$-0.56$-0.55$-0.55
High Forecast$0.39$0.34$0.19$0.10$-0.24$-0.29$-0.33$-0.33$-0.44$-0.55$-0.66$-0.67$-0.71$-0.92$-1.04$-1.11$-1.36$-1.44$-1.50$-1.49$-1.31$-1.29$-1.12$-1.02$-0.62$-0.68$-0.59$-0.56$-0.55$-0.55
Low Forecast$0.35$0.30$0.17$0.09$-0.27$-0.32$-0.37$-0.43$-0.53$-0.61$-0.73$-0.75$-0.84$-1.02$-1.16$-1.23$-1.51$-1.44$-1.50$-1.49$-1.31$-1.29$-1.12$-1.02$-0.62$-0.68$-0.59$-0.56$-0.55$-0.55
Surprise %-------------0.99%0.89%1.06%1.02%0.87%1.00%0.98%1.16%1.26%1.17%0.73%1.52%1.06%1.27%0.80%0.82%0.60%

According to undefined Wall Street analysts, Natera's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to NTRA previous annual EPS of $NaN (undefined).

Natera Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
DRIODarioHealth$0.71$10.751414.08%Buy
PSNLPersonalis$3.84$7.3892.19%Hold
CDNACareDx$22.14$37.5069.38%Buy
NEOGNeogen$12.13$17.5044.27%Buy
CSTLCastle Biosciences$28.14$40.5043.92%Buy
EXASExact Sciences$60.37$77.4328.26%Buy
GHGuardant Health$34.84$40.6016.53%Buy
NEONeoGenomics$17.55$19.008.26%Buy
QGENQiagen$45.34$48.336.59%Buy
ILMNIllumina$143.12$147.783.26%Buy
TWSTTwist Bioscience$48.40$46.00-4.96%Buy
NTRANatera$168.21$151.50-9.93%Buy

NTRA Forecast FAQ

Is Natera a good buy?

Yes, according to 11 Wall Street analysts, Natera (NTRA) is considered a 'Buy'. The rating consensus is based on 1 'Strong Buy' and 10 'Buy' recommendations, accounting for 100.00% of NTRA's total ratings.

What is NTRA's price target?

Natera (NTRA) average price target is $151.5 with a range of $132 to $182, implying a -6.41% from its last price of $161.88. The data is based on 11 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Natera stock go up soon?

According to Wall Street analysts' prediction for NTRA stock, the company can go down by -6.41% (from the last price of $161.88 to the average price target of $151.5), up by 12.43% based on the highest stock price target, and down by -18.46% based on the lowest stock price target.

Can Natera stock reach $200?

NTRA's average twelve months analyst stock price target of $151.5 does not support the claim that Natera can reach $200 in the near future.

What are Natera's analysts' financial forecasts?

Natera's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $1.8B (high $1.89B, low $1.75B), average EBITDA is $-931M (high $-904M, low $-974M), average net income is $-161M (high $-147M, low $-172M), average SG&A $1.28B (high $1.34B, low $1.25B), and average EPS is $-1.302 (high $-1.191, low $-1.39). NTRA's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $2.22B (high $2.33B, low $2.14B), average EBITDA is $-1.145B (high $-1.107B, low $-1.202B), average net income is $118.16M (high $125.72M, low $113.08M), average SG&A $1.58B (high $1.66B, low $1.53B), and average EPS is $0.955 (high $1.02, low $0.914).

Did the NTRA's actual financial results beat the analysts' financial forecasts?

Based on Natera's last annual report (Dec 2023), the company's revenue was $1.08B, beating the average analysts forecast of $1.03B by 5.30%. Apple's EBITDA was $-446M, missing the average prediction of $-563M by -20.77%. The company's net income was $-435M, missing the average estimation of $-504M by -13.73%. Apple's SG&A was $618.31M, missing the average forecast of $736.64M by -16.06%. Lastly, the company's EPS was $-3.78, missing the average prediction of $-3.971 by -4.80%. In terms of the last quarterly report (Sep 2023), Natera's revenue was $268.31M, beating the average analysts' forecast of $259.27M by 3.48%. The company's EBITDA was $-106M, missing the average prediction of $-134M by -21.18%. Natera's net income was $-109M, missing the average estimation of $-119M by -8.03%. The company's SG&A was $154.74M, missing the average forecast of $184.82M by -16.28%. Lastly, the company's EPS was $-0.95, missing the average prediction of $-0.958 by -0.81%